Clinical case of anti-NMDA receptor encephalitis associated with new coronaviral infection (COVID-19)-Reference-Cited by-同舟云学术

Clinical case of anti-NMDA receptor encephalitis associated with new coronaviral infection (COVID-19)

Published:2022-03-08 Issue:1 Volume:27 Page:106-112
ISSN:2686-7192
Container-title:Russian neurological journal
language:
Short-container-title:РНЖ

Author:

Khoreva M. A.¹^ORCID,Serikova I. Y.²^ORCID,Smagina I. V.¹^ORCID,Golenko A. A.³^ORCID,Smirnov K. V.³^ORCID,Zavyalov A. E.²^ORCID,Draganic I. A.²^ORCID

Affiliation:

1. Altai state medical University

2. Altai state medical University; Altai Regional Clinical Center for Maternal and Child Health

3. Altai Regional Clinical Center for Maternal and Child Health

Abstract

During the outbreak of coronavirus disease 2019 (COVID-19) clinicians are increasingly involved in the observation of possible neurological complications due to the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some cases of encephalitis following COVID‐19 pandemic have been reported in literature that can mean possible damage to the central nervous system related to the SARS-CoV-2 infection. Early on, this was thought to be due to the direct effects of the virus itself, but the possibility of immune system mechanisms being implicated was gradually raised in scientific literature. The reports of anti‐NMDA receptor encephalitis among patients with COVID‐19 at different ages may be signs of this condition. We report the case of 16-year teenager with concomitant Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) encephalitis and COVID‐19. This clinical case brings arguments on the possible relationship between SARS-CoV-2 infection and autoimmune encephalitis.

Publisher

Medical Informational Agency Publishers

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology

Reference21 articles.

1. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020;92(6):552–555. https://doi.org/10.1002/jmv.25728

2. Ermis U., Rust M.I., Bungenberg J., Costa A., Dreher M., Balfanz P. et al. Neurological symptoms in COVID-19: a crosssectional monocentric study of hospitalized patients. Neurological Research and Practice. 2021;3(1):17. https://doi.org/10.1186/s42466-021-00116-1

3. Yassin A., Nawaiseh M., Shaban A., Alsherbini K., El-Salem K., Soudah O., Abu-Rub M. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol. 2021;21(1):138. https://doi.org/10.1186/s12883-021-02161-4

4. Jha N.K., Ojha S., Jha S.K., Dureja H., Singh S.K., Shukla S.D. et al. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J. Mol. Neurosci. 2021:1–18. https://doi.org/10.1007/s12031-020-01767-6

5. Lewis A., Frontera J., Placantonakis D.G., Lighter J., Galetta S., Balcer L., Melmed K.R. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J. Neurol. Sci. 2021;421:117316. https://doi.org/10.1016/j.jns.2021.117316

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis;Translational Psychiatry;2024-03-08

2. Autoimmune аnti-NMDA encephalitis associated with the new coronavirus infection COVID-19;Russian neurological journal;2023-10-02

3. COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis;Autoimmunity Reviews;2023-09